Ignite Creation Date:
2025-12-24 @ 1:56 PM
Ignite Modification Date:
2025-12-30 @ 9:43 PM
Study NCT ID:
NCT05046795
Status:
COMPLETED
Last Update Posted:
2024-11-01
First Post:
2021-09-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Revefenacin in Chinese Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease(COPD)
Sponsor:
Mylan Pharma UK Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-10
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-26
Completion Date Type:
ACTUAL
First Submit Date:
2021-09-07
First Submit QC Date:
None
Study First Post Date:
2021-09-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-07-22
Results First Submit QC Date:
None
Results First Post Date:
2024-11-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-30
Last Update Post Date:
2024-11-01
Last Update Post Date Type:
ACTUAL